Semaglutide 5mg: Weight Loss Research Peptide (2nd Photo of COA)

Description

Legal Disclaimer

This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. Semaglutide is not approved for medical use, human consumption, or as a therapeutic treatment in this context.

Product Details

  • Quantity: 5 mg
  • Packaging: Secure, sealed, and tamper-proof vials
  • Source: Werner Science, High-quality lab-grade peptide, Third-party tested
  • Note: This product is sold in powder form and must be reconstituted before use.

Overview

Semaglutide 5mg — a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist designed primarily for advanced diabetes management and weight control research. Known for its efficacy in improving glycemic control and promoting significant weight loss, semaglutide has become an essential compound in studies related to metabolic disorders.

Research Specifics

Semaglutide exhibits potent therapeutic properties that make it an attractive subject for researchers investigating type 2 diabetes mellitus (T2DM) management and obesity treatment. Its ability to stimulate insulin secretion while suppressing glucagon release positions it as a valuable tool in regulating blood sugar levels. Additionally, semaglutide has shown promise in reducing body weight by decreasing hunger and food cravings.

Furthermore, semaglutide may offer cardiovascular risk reduction benefits due to its effects on lipid metabolism and blood pressure regulation.

However, safety findings have noted an association between semaglutide treatment and increased risk of retinopathy complications in patients with preexisting diabetic retinopathy.

Key Features

  • Amino Acid Sequence: Not specified here; typically involves modifications of natural GLP-1.
  • Molecular Weight: Approximately 4 kDa.
  • Purity: High-quality lab-grade purity suitable for advanced research applications.

Potential Applications

Researchers are exploring semaglutide’s role in:

  • Enhancing glycemic control through improved insulin sensitivity.
  • Promoting significant weight loss by reducing appetite.
  • Investigating potential cardiovascular protective effects.

Specifications

This product comes packaged securely to ensure stability during storage. It requires reconstitution before use according to specific protocols suitable for laboratory settings.

______________________

Citations:

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC6099440/

[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC6231279/

[3] https://apcz.umk.pl/JEHS/article/view/51699

[4] https://journals.viamedica.pl/clinical_diabetology/article/view/102374

[5] https://www.nature.com/articles/s41591-024-02996-7

[6] https://journals.viamedica.pl/clinical_diabetology/article/view/103963/81142

[7] https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.15911

Return To: All Research Peptides

Reviews

There are no reviews yet.

Be the first to review “Semaglutide 5mg: Weight Loss Research Peptide (2nd Photo of COA)”

Your email address will not be published. Required fields are marked *

Please Choose Your Country